US20100137358A1
(en)
*
|
1996-11-05 |
2010-06-03 |
Dr. Reddy's Laboratories Ltd. |
Solifenacin compositions
|
WO2008128028A2
(en)
*
|
2007-04-11 |
2008-10-23 |
Dr. Reddy's Laboratories Ltd. |
Solifenacin compositions
|
FR2772378B1
(fr)
*
|
1997-12-12 |
2000-02-04 |
Synthelabo |
Derives d'imidazole, leur preparation et leur application en therapeutique
|
US7214687B2
(en)
|
1999-07-14 |
2007-05-08 |
Almirall Ag |
Quinuclidine derivatives and medicinal compositions containing the same
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
JP2001316670A
(ja)
*
|
2000-05-02 |
2001-11-16 |
Dainippon Ink & Chem Inc |
液晶組成物
|
ES2213703T5
(es)
*
|
2000-06-27 |
2011-11-02 |
Laboratorios S.A.L.V.A.T., S.A. |
Carbamatos derivados de arilalquilaminas.
|
WO2002051841A1
(en)
*
|
2000-12-22 |
2002-07-04 |
Almirall Prodesfarma Ag |
Quinuclidine carbamate derivatives and their use as m3 antagonists
|
AU2002238471B2
(en)
|
2000-12-28 |
2007-06-28 |
Almirall, S.A. |
Quinuclidine derivatives and their use as M3 antagonists
|
ES2359719T3
(es)
*
|
2001-07-10 |
2011-05-26 |
Astellas Pharma Inc. |
Composición farmacéutica comprendiendo quinuclidin-3'-il 1-fenil-1,2,3,4-tetrahidroisoquinolin-2-carboxilato para el tratamiento de la cistitis instersticial y/o la prostatitis no bacteriana.
|
BR0215348A
(pt)
*
|
2001-12-20 |
2004-11-16 |
S A L V A T Lab Sa |
Derivados de carbamato de 1-alquil-1-azoniabiciclo[2-2]octano e uso destes como antagonistas do receptor muscarìnico
|
WO2003103659A1
(ja)
*
|
2002-06-07 |
2003-12-18 |
山之内製薬株式会社 |
過活動膀胱治療剤
|
ES2203327B1
(es)
|
2002-06-21 |
2005-06-16 |
Almirall Prodesfarma, S.A. |
Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
|
ES2204295B1
(es)
|
2002-07-02 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de quinuclidina-amida.
|
CN1668585A
(zh)
|
2002-07-08 |
2005-09-14 |
兰贝克赛实验室有限公司 |
用作蝇蕈碱受体拮抗剂的3,6-二取代氮杂双环[3.1.0]己烷衍生物
|
DE60226906D1
(de)
|
2002-07-31 |
2008-07-10 |
Ranbaxy Lab Ltd |
3,6-disubstituierte azabicyclo ä3.1.0ühexanderivate, die sich als muscarinrezeptorantagonisten eignen
|
WO2004014363A1
(en)
|
2002-08-09 |
2004-02-19 |
Ranbaxy Laboratories Limited |
3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonist
|
EP1534675B1
(en)
|
2002-08-23 |
2009-02-25 |
Ranbaxy Laboratories, Ltd. |
Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo¬3.1.0 hexane derivatives as muscarinic receptor antagonists
|
BR0315784A
(pt)
*
|
2002-10-29 |
2005-09-20 |
Pharmacia & Upjohn Co Llc |
Compostos de amÈnio quaternário
|
DE60227576D1
(de)
|
2002-12-10 |
2008-08-21 |
Ranbaxy Lab Ltd |
3,6-DISUBSTITUIERTE AZABICYCLO i3.1.0 -HEXANDERIVATIVE ALS ANTAGONISTEN DES MUSCARINREZEPTORS
|
BR0317606A
(pt)
*
|
2002-12-20 |
2005-11-29 |
Dynogen Pharmaceuticals Inc |
Métodos de tratamento de distúrbios não dolorosos da bexiga urinária que usam moduladores de canal de cálcio de subunidade (alfa)2(delta)
|
ATE386738T1
(de)
*
|
2002-12-23 |
2008-03-15 |
Ranbaxy Lab Ltd |
Flavaxat-derivate als muscarin-rezeptor antagonisten
|
AU2002347552A1
(en)
|
2002-12-23 |
2004-07-14 |
Ranbaxy Laboratories Limited |
1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
|
US7488748B2
(en)
|
2003-01-28 |
2009-02-10 |
Ranbaxy Laboratories Limited |
3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
|
US20040198822A1
(en)
*
|
2003-03-21 |
2004-10-07 |
Dynogen Pharmacueticals, Inc. |
Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulators
|
AU2003214520A1
(en)
|
2003-04-09 |
2004-11-01 |
Ranbaxy Laboratories Limited |
Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
|
ATE362364T1
(de)
|
2003-04-10 |
2007-06-15 |
Ranbaxy Lab Ltd |
Substituierte azabicyclo hexane derivate als muscarin rezeptor antagonisten
|
AU2003223010A1
(en)
|
2003-04-10 |
2004-11-01 |
Ranbaxy Laboratories Limited |
Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
|
BRPI0409302A
(pt)
|
2003-04-11 |
2006-04-11 |
Ranbaxy Lab Ltd |
derivados azabiciclo como antagonistas de recetores muscarìnicos, método para sua preparação e composição farmacêutica contendo os mesmos
|
WO2004091597A2
(en)
*
|
2003-04-15 |
2004-10-28 |
Pharmacia & Upjohn Company Llc |
Method of treating irritable bowel syndrome (ibs)
|
US20050175689A1
(en)
*
|
2003-10-27 |
2005-08-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Coated fine particles containing drug for intrabuccally fast disintegrating tablet
|
JPWO2005075474A1
(ja)
*
|
2004-02-09 |
2007-10-11 |
アステラス製薬株式会社 |
コハク酸ソリフェナシン含有組成物
|
WO2005077364A1
(ja)
*
|
2004-02-18 |
2005-08-25 |
Yamanouchi Pharmaceutical Co., Ltd. |
ソリフェナシンの経皮投与製剤およびその経皮透過改善方法
|
EP1726304A4
(en)
*
|
2004-03-16 |
2010-04-28 |
Astellas Pharma Inc |
COMPOSITION CONTAINING SOLIFENACIN
|
JPWO2005087231A1
(ja)
*
|
2004-03-16 |
2008-01-24 |
アステラス製薬株式会社 |
ソリフェナシン含有組成物
|
ZA200608614B
(en)
*
|
2004-03-25 |
2008-06-25 |
Astellas Pharma Inc |
Composition for solid pharmaceutical preparation of solifenacin or salt thereof
|
RU2359670C2
(ru)
*
|
2004-03-25 |
2009-06-27 |
Астеллас Фарма Инк. |
Композиция солифенацина или его соли для использования в твердом препарате
|
WO2006035280A1
(en)
*
|
2004-09-27 |
2006-04-06 |
Ranbaxy Laboratories Limited |
3,4-dihydroisoquinoline compounds as muscrinic receptor antagonists for the treatment of respiratory, urinary and gastrointestinal diseases
|
WO2006035303A1
(en)
*
|
2004-09-29 |
2006-04-06 |
Ranbaxy Laboratories Limited |
Muscarinic receptor antagonists
|
RU2397767C2
(ru)
*
|
2004-12-27 |
2010-08-27 |
Астеллас Фарма Инк. |
Стабильная, состоящая из частиц фармацевтическая композиция, содержащая солифенацин или его соль
|
US20080103171A1
(en)
*
|
2004-12-27 |
2008-05-01 |
Astellas Pharma Inc. |
Stable Particular Pharmaceutical Composition of Solifenacin or Salt Thereof
|
JPWO2006090759A1
(ja)
*
|
2005-02-25 |
2008-07-24 |
アステラス製薬株式会社 |
ソリフェナシン含有医薬
|
JP3701964B1
(ja)
*
|
2005-03-08 |
2005-10-05 |
アステラス製薬株式会社 |
キヌクリジン誘導体の新規な塩
|
US20080255188A1
(en)
*
|
2005-07-11 |
2008-10-16 |
Naresh Kumar |
Muscarinic Receptor Antagonists
|
US7815939B2
(en)
|
2005-07-20 |
2010-10-19 |
Astellas Pharma Inc. |
Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
|
EP1948164A1
(en)
|
2005-10-19 |
2008-07-30 |
Ranbaxy Laboratories, Ltd. |
Pharmaceutical compositions of muscarinic receptor antagonists
|
JP2008535931A
(ja)
*
|
2005-12-21 |
2008-09-04 |
テバ ファーマシューティカル インダストリーズ リミティド |
ソリフェナシンの調製方法
|
CZ300699B6
(cs)
*
|
2006-06-21 |
2009-07-22 |
Zentiva, A. S. |
Zpusob prípravy solifenacinu
|
US20090326230A1
(en)
*
|
2006-07-19 |
2009-12-31 |
Dr. Reddy's Laboratories Ltd. |
Process for preparing solifenacin and its salts
|
ES2298049B1
(es)
|
2006-07-21 |
2009-10-20 |
Laboratorios Almirall S.A. |
Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
|
US20080114028A1
(en)
*
|
2006-07-24 |
2008-05-15 |
Tamas Koltai |
Process for preparing polymorphic forms of solifenacin succinate
|
US20080114029A1
(en)
*
|
2006-08-03 |
2008-05-15 |
Tamas Koltai |
Polymorphs of solifenacin intermediate
|
TW200825084A
(en)
*
|
2006-11-14 |
2008-06-16 |
Astrazeneca Ab |
New compounds 521
|
US20100029944A1
(en)
*
|
2006-11-22 |
2010-02-04 |
Corporacion Medichem, S.L. |
Process for the Synthesis of Solifenacin
|
CZ300692B6
(cs)
*
|
2006-12-22 |
2009-07-15 |
Zentiva, A. S. |
Zpusob prípravy solifenacinu
|
US7741489B2
(en)
*
|
2007-03-30 |
2010-06-22 |
Medichem S.A. |
Process for the synthesis of solifenacin
|
WO2009011844A1
(en)
*
|
2007-07-13 |
2009-01-22 |
Teva Pharmaceutical Industries Ltd. |
Processes for solifenacin preparation
|
CN101754760A
(zh)
*
|
2007-07-20 |
2010-06-23 |
安斯泰来制药株式会社 |
用以改善伴随着前列腺肥大的下尿路症状的药物组合物
|
EP2018850A1
(en)
*
|
2007-07-24 |
2009-01-28 |
Ratiopharm GmbH |
Pharmaceutical composition comprising solifenacin or a pharmaceutically acceptable salt thereof
|
US20100240697A1
(en)
*
|
2007-11-02 |
2010-09-23 |
Astellas Pharma Inc. |
Pharmaceutical composition for treating overactive bladder
|
EP2489666A3
(en)
*
|
2007-12-04 |
2012-12-26 |
Cadila Healthcare Limited |
Chemically and chirally pure solifenacin base and its salts
|
US8476297B2
(en)
|
2007-12-04 |
2013-07-02 |
Amgen Inc. |
TRP-M8 receptor ligands and their use in treatments
|
ITMI20080195A1
(it)
|
2008-02-08 |
2009-08-09 |
Dipharma Francis Srl |
Procedimento per la preparazione di solifenacin
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
CA2718411C
(en)
|
2008-03-27 |
2016-02-16 |
Chase Pharmaceuticals Corporation |
Use and composition for treating dementia
|
PL385264A1
(pl)
|
2008-05-23 |
2009-12-07 |
Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna |
Sposób wytwarzania enancjomerycznie czystej (S)-1-fenylo-1, 2, 3, 4-tetrahydroizochinoliny
|
PL385265A1
(pl)
|
2008-05-23 |
2009-12-07 |
Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna |
Sposób wytwarzania solifenacyny i/lub jej soli o wysokiej czystości farmaceutycznej
|
EP2310387A2
(en)
|
2008-07-29 |
2011-04-20 |
KRKA, D.D., Novo Mesto |
A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
|
EP2181707A1
(en)
|
2008-11-04 |
2010-05-05 |
Astellas Ireland Co., Ltd. |
Combined use of an alpha-adrenergic receptor antagonist and an anti-muscarinic agent
|
BRPI1007484B1
(pt)
|
2009-02-04 |
2019-04-16 |
Astellas Pharma Inc. |
Composição farmacêutica formulada para administração oral compreendendo uma camada compreendendo uma porção de liberação modificada e uma camada compreendendo uma porção de liberação imediata
|
US8283470B2
(en)
|
2009-03-09 |
2012-10-09 |
Megafine Pharma(P) Ltd. |
Method for the preparation of solifenacin and intermediate thereof
|
US20100273825A1
(en)
*
|
2009-03-30 |
2010-10-28 |
Astellas Pharma Inc. |
Solid pharmaceutical composition containing solifenacin amorphous form
|
WO2011048607A1
(en)
*
|
2009-09-25 |
2011-04-28 |
Cadila Healthcare Limited |
Processes for the preparation of solifenacin or a salt thereof
|
PL234208B1
(pl)
|
2010-01-18 |
2020-01-31 |
Zakl Farmaceutyczne Polpharma Spolka Akcyjna |
Sposób wytwarzania bursztynianu solifenacyny
|
ES2604705T3
(es)
|
2010-03-31 |
2017-03-08 |
Ono Pharmaceutical Co., Ltd. |
Agente preventivo y/o remedio para el síndrome mano-pie
|
AU2011245499B2
(en)
|
2010-04-30 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
Novel beta 3 adrenergic receptor agonists
|
RS55044B1
(sr)
|
2010-05-19 |
2016-12-30 |
Astellas Pharma Inc |
Farmaceutska kompozicija koja sadrži solifenacin
|
WO2012001481A1
(en)
|
2010-06-28 |
2012-01-05 |
Aurobindo Pharma Limited |
Novel process for the preparation of solifenacin succinate
|
JP5826262B2
(ja)
|
2010-07-05 |
2015-12-02 |
クリスタル ファーマ,エセ.ア.ウ. |
ソリフェナシン塩
|
CA2817336A1
(en)
|
2010-11-11 |
2012-05-18 |
Hexal Ag |
Crystalline solifenacin succinate
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
BR112013028755A2
(pt)
|
2011-05-10 |
2017-01-31 |
Theravida Inc |
combinações de solifenacina e estimulantes salivares para o tratamento de bexiga hiperativa
|
EP2723734A1
(en)
|
2011-06-22 |
2014-04-30 |
Isochem |
Process for the preparation of solifenacin and salts thereof
|
KR101365849B1
(ko)
|
2012-03-28 |
2014-02-24 |
경동제약 주식회사 |
솔리페나신 또는 그의 염의 제조방법 및 이에 사용되는 신규 중간체
|
CN104411687A
(zh)
|
2012-07-02 |
2015-03-11 |
法尔玛赞公司 |
一种用于制备索非那新或其盐的方法
|
WO2014034860A1
(ja)
|
2012-08-31 |
2014-03-06 |
アステラス製薬株式会社 |
経口投与用医薬組成物
|
CN104768540A
(zh)
|
2012-09-05 |
2015-07-08 |
才思制药公司 |
抗胆碱能神经保护组合物和方法
|
CN103787969B
(zh)
|
2012-10-30 |
2016-07-06 |
上海京新生物医药有限公司 |
一种(1s)-1-苯基-3,4-二氢-2(1h)-异喹啉甲酸酯的制备方法
|
TW201427977A
(zh)
*
|
2012-12-06 |
2014-07-16 |
Chiesi Farma Spa |
具有蕈毒鹼受體拮抗劑及β2腎上腺素受體致效劑活性之化合物
|
EP2778167A1
(en)
|
2013-03-11 |
2014-09-17 |
Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi |
Stable pharmaceutical composition comprising amorphous solifenacin or its pharmaceutically acceptable salt
|
CA2921621C
(en)
*
|
2013-07-13 |
2018-08-28 |
Beijing Fswelcome Technology Development Co., Ltd |
Quinine compounds, and optical isomers, preparation method and medical use thereof
|
WO2015171753A1
(en)
|
2014-05-06 |
2015-11-12 |
Visco Anthony G |
Methods of treating or preventing preterm labor
|
CN104592221A
(zh)
*
|
2015-01-26 |
2015-05-06 |
中山奕安泰医药科技有限公司 |
一种合成索非那新的工艺
|
KR20160146428A
(ko)
|
2015-06-12 |
2016-12-21 |
한미정밀화학주식회사 |
솔리페나신 또는 그의 약학적으로 허용되는 염과 락토즈를 포함하는 안정한 무정형 솔리페나신 약학 조성물 및 그의 제조방법
|
KR102148414B1
(ko)
|
2017-05-15 |
2020-08-26 |
주식회사 서울제약 |
솔리페나신을 유효성분으로 하는 구강붕해필름
|
WO2019118528A1
(en)
*
|
2017-12-12 |
2019-06-20 |
Arkuda Therapeutics |
Progranulin modulators and methods of using the same
|
US20220251084A1
(en)
*
|
2019-06-12 |
2022-08-11 |
Arkuda Therapeutics |
Progranulin modulators and methods of using the same
|
CN113200979A
(zh)
*
|
2021-04-13 |
2021-08-03 |
上海予君生物科技发展有限公司 |
一种琥珀酸索非那新的合成工艺
|